文献速递临床试验与 GCP

行为与盆底肌训练联合手术治疗对混合性尿失禁女性症状的影响:ESTEEM随机临床试验

Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

ESTEEM随机临床试验纳入美国9个中心的480例混合性尿失禁女性,比较行为与盆底肌训练联合尿道中段吊带术与单纯吊带术。12个月时联合组UDI评分较基线下降128.1分,单纯手术组下降114.7分,组间差异-13.4分(95%CI -25.9至-1.0;P=0.04),未达35分的临床重要差异阈值。

要点

  • 联合组与单纯手术组12个月UDI评分均较基线显著下降。
  • 组间UDI评分差异-13.4分(95%CI -25.9至-1.0;P=0.04),未达临床重要差异阈值35分。
  • 相关与不相关严重不良事件发生率联合组8.7%、单纯手术组11.8%。

核心结论

  • 在混合性尿失禁女性中,行为与盆底肌训练联合尿道中段吊带术相比单纯手术,12个月时尿失禁症状差异有统计学意义但幅度小,未达预设的临床重要性阈值。

研究设计与样本

  • 美国9个中心开展的随机临床试验,纳入21岁及以上、中重度压力性和急迫性尿失禁症状至少3个月、3天膀胱日记至少各1次漏尿事件的女性。
  • 2013年10月至2016年4月入组,末次随访2017年10月;480例随机(平均年龄54.0岁[SD 10.7]),464例符合条件,416例(86.7%)有基线后结局数据纳入主要分析。
  • 干预为行为与盆底肌训练(术前1次、术后5次,至6个月)联合尿道中段吊带术(n=209)对比单纯吊带术(n=207)。

主要发现

  • 联合组UDI评分从基线178.0分降至12个月30.7分,校正平均变化-128.1分(95%CI -146.5至-109.8)。
  • 单纯手术组UDI评分从176.8分降至34.5分,校正平均变化-114.7分(95%CI -133.3至-96.2)。
  • 模型估计组间差异-13.4分(95%CI -25.9至-1.0;P=0.04),未达最小临床重要差异阈值35分。
  • 相关与不相关严重不良事件发生率总体10.2%,联合组8.7%,单纯手术组11.8%。

关键数值与推荐

  • 主要结局为基线与12个月之间UDI长表评分变化,范围0至300分,最小临床重要差异35分,分数越高症状越重。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mixed urinary incontinence, including both stress and urgency incontinence, has adverse effects on a woman's quality of life. Studies evaluating treatments to simultaneously improve both components are lacking. OBJECTIVE: To determine whether combining behavioral and pelvic floor muscle therapy with midurethral sling is more effective than sling alone for improving mixed urinary incontinence symptoms. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial involving women 21 years or older with moderate or severe stress and urgency urinary incontinence symptoms for at least 3 months, and at least 1 stress and 1 urgency incontinence episode on a 3-day bladder diary. The trial was conducted across 9 sites in the United States, enrollment between October 2013 and April 2016; final follow-up October 2017. INTERVENTIONS: Behavioral and pelvic floor muscle therapy (included 1 preoperative and 5 postoperative sessions through 6 months) combined with midurethral sling (n = 209) vs sling alone (n = 207). MAIN OUTCOMES AND MEASURES: The primary outcome was change between baseline and 12 months in mixed incontinence symptoms measured by the Urogenital Distress Inventory (UDI) long form; range, 0 to 300 points; minimal clinically important difference, 35 points, with higher scores indicating worse symptoms. RESULTS: Among 480 women randomized (mean [SD] age, 54.0 years [10.7]), 464 were eligible and 416 (86.7%) had postbaseline outcome data and were included in primary analyses. The UDI score in the combined group significantly decreased from 178.0 points at baseline to 30.7 points at 12 months, adjusted mean change -128.1 points (95% CI, -146.5 to -109.8). The UDI score in the sling-only group significantly decreased from 176.8 to 34.5 points, adjusted mean change -114.7 points (95% CI, -133.3 to -96.2). The model-estimated between-group difference (-13.4 points; 95% CI, -25.9 to -1.0; P = .04) did not meet the minimal clinically important difference threshold. Related and unrelated serious adverse events occurred in 10.2% of the participants (8.7% combined and 11.8% sling only). CONCLUSIONS AND RELEVANCE: Among women with mixed urinary incontinence, behavioral and pelvic floor muscle therapy combined with midurethral sling surgery compared with surgery alone resulted in a small statistically significant difference in urinary incontinence symptoms at 12 months that did not meet the prespecified threshold for clinical importance. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01959347.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Sung VW, Borello-France D, Newman DK, et al. Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial. JAMA. 2019. PMID: 31529007. doi:10.1001/jama.2019.12467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。